期刊文献+

β-tubulinⅢ在进展期胃癌组织中的表达及临床意义 被引量:1

Expression and clinical significance of β- tubulinⅢ in advanced gastric cancer tissue
下载PDF
导出
摘要 目的探讨β-tubulinⅢ在胃癌组织中的表达,与肿瘤临床特征的关系及其对含紫杉烷类药物辅助化疗患者无病生存期(DFS)和总生存期(OS)的影响。方法收集34例胃癌根治术后应用含紫杉烷类药物辅助化疗且已经死亡患者的完整资料。应用免疫组织化学方法检测β-tubulinⅢ在术后病理组织中的表达,采用χ2检验分析β-tubulinⅢ表达与肿瘤临床特征的关系。采用Kaplan-Meier方法分析β-tubulinⅢ表达对含紫杉烷类药物辅助化疗患者生存期的影响。结果 (1)在34例胃癌患者中,β-tubulinⅢ表达15例,阳性表达率44.1%。β-tubulinⅢ的表达与肿瘤发病部位、大小、浸润深度、组织学类型、淋巴结转移、TNM分期无关。(2)β-tubulinⅢ阳性表达患者DFS 10个月,中位OS 18个月;β-tubulinⅢ阴性表达患者DFS 15个月,中位OS为21个月。β-tubulinⅢ阴性表达与阳性表达患者的DFS及中位OS相比,差异有显著性意义,P<0.05。结论β-tubulinⅢ在胃癌组织中的表达可能作为胃癌根治术后接受紫杉烷类药物敏感性的预测指标,但与肿瘤临床特征无关。 Objective To explore the correlation between the expression of β-tubulinⅢin gastric cancer tissues and clin-ical features of tumor, and to explore the effects of β-tubulinⅢon the disease free survival (DFS) and overall survival ( OS) of the patients treated with taxanes as adjuvant chemotherapy .Methods We have collected 34 patients who accepted radical resection of gastric cancer and taxanes as postoperative adjuvant chemotherapy .And all the 34 patients have died . The expression of β-tubulinⅢ was detected by immunohistochemical method .The correlation between the expression ofβ-tubulin Ⅲin gastric tissues and clinical features of tumor was analyzed by χ2 test.The correlation between the expres-sion of β-tubulin Ⅲon the survival of patients with taxanes as adjuvant chemot herapy was analyzed by Kaplan -Meier approach.Results In 34 cases of gastric cancer patients , 15 cases have β-tubulin Ⅲ expression,the positive expression rate is 44 .1%. The expression of β-tubulin Ⅲhas no correlation with tumor site ,size of tumor ,depth of invasion ,histo-logical type,lymphatic metastasis and TNM stage .The disease free survival (DFS) of patients with positive expression of β-tubulin Ⅲwas 10 months,and 18 months of overall survival(OS).The disease free survival(DFS) of patients with nega-tive expression ofβ-tubulinⅢwas 15 months,and 21 months of overall survival(OS).Compared positive expression of β-tubulin Ⅲpatients,the negatives have significant difference in DFS and median OS , P〈0.05.Conclusion The expres-sion of β-tubulinⅢin gastric tissues can be used as predictive indicators taxane drug sensitivity ,which after gastric cancer radical surgery , but does not correlate to the characteristics of clinical oncology .
出处 《大连医科大学学报》 CAS 2014年第3期225-228,261,共5页 Journal of Dalian Medical University
基金 大连市科委课题项目(2010ESF002)
关键词 胃癌 β-tubulinⅢ 紫杉烷类 预后 gastric cancer β-tubulinⅢ taxanes prognosis
  • 相关文献

参考文献9

  • 1吴玉婷,余秉翔.ERCCl、RRM1、class β-tubulin基因在105例非小细胞肺癌患者中共表达规律的研究[J/CD].中华临床医师杂志:电子版,2013,7(1):98-103. 被引量:1
  • 2Edelman MJ,Schneider CP,Tsai CM,et al.Randomized phase Ⅱ study of ixabepilone or paelitaxel plus earboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin status [ J ].J Clin Oncol,2013,31(16):1990-1996. 被引量:1
  • 3Koh Y,Jang B,Han SW,et al.Expression of class Ⅲ be-ta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer [ J ].J Thorac Oncol,2010,5(3):320-325. 被引量:1
  • 4Semiglazova TIu,Klimenko VV,Filatova LV,et al.Mark-ers of effectiveness of preoperative taxane-based chemo-therapy for locally advanced breast cancer [ J ].Vopr Onkol,2013,59(3):363-367. 被引量:1
  • 5Roque DM,Bellone S,English DP,et al.Tubulin-β-Ⅲ overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapyand sensitivity to epothilones [ J].Cancer,2013,119(14):2582-2592. 被引量:1
  • 6Roque DM,BeUone S,Buza N,et al.Class Ⅲ β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone [ J ].Am J Ob-stet Gynecol,2013,209(1):62. 被引量:1
  • 7Koh Y,Kim TM,Jeon YK,et al.Class Ⅲ beta-tubulin,but not ERCC1,is a strong predictive and prognostic mark-er in locally advanced head and neck squamous cell carci-noma[J].Ann Oncol,2009,20(8):1414-1419. 被引量:1
  • 8Hwang JE,Hong JY,Kim K,et al.Class Ⅲ beta-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer[J].BMC Cancer,2013,13(1):431. 被引量:1
  • 9Urano N,Fujiwara Y,Doki Y,et al.Clinical significance of class Ⅲ beta-tubulin expression and its predictive val-ue for resistance to docetaxel-based chemotherapy in gas-tric cancer[J].Int J Oneol,2006,28(2):375-381. 被引量:1

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部